From: Vasculogenic mimicry in carcinogenesis and clinical applications
LncRNA | Cancer type | Cancer cell lines | miRNA | Signaling pathway | Effect of VM formation | Reference |
---|---|---|---|---|---|---|
MALAT1 | Gastric cancer | BGC823 SGC7901 | miR-376a | ERK/MMP FAK/paxillin pathway | Promote | |
MALAT1 | Lung cancer | H1299 H292 | miR-145-5p | lncRNA-MALAT1/miR-145-5p/NEDD9 pathway | Promote | [70] |
LINC00339 | Glioma | U87 U251 | miR-539-5P | miR-539-5P/Twist1/MMPs pathway | Promote | [89] |
LncRNA n339260 | Hepatocellular carcinoma | HepG2 | - | TGF-β pathway | Promote | [68] |
LncRNA HOXA-AS2 | Glioma | U87 U251 | miR-373 | miR-373/EGFR pathway | Promote | [90] |
LncRNA TP73-AS1 | Triple negative breast cancer | MDA-MB-231 | miR-490-3P | miR-490-3p/Twist1 pathway | Promote | [94] |
LINC00312 | Lung adenocarcino-ma | H1299 PC-9 | - | YBX1/AKT/TGF-β pathway | Promote | [26] |
SNHG20 | Glioma | U87 U251 | - | ZRANB2/SNHG20/FOXK1 pathway | Promote | [73] |